{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "28",
                "@timestamp": "2022-06-28T11:11:10.000010-04:00",
                "@year": "2022",
                "@month": "06"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {"xocs:funding-agency-matched-string": "Thailand International Cooperation Agency"},
            "xocs:funding-addon-generated-timestamp": "2021-05-22T11:24:40.826Z",
            "xocs:funding-text": "This review was supported by Thailand International Cooperation Agency Scholarship.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@afid": "60028190",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Food and Pharmaceutical Chemistry"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "affiliation-id": {
                            "@afid": "60028190",
                            "@dptid": "104425859"
                        },
                        "@affiliation-instance-id": "2005167463-1d82c7f35f0e56f05c349c6d4ab207be",
                        "ce:source-text": "Department of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand",
                        "@dptid": "104425859"
                    },
                    "author": [
                        {
                            "ce:given-name": "Daylia",
                            "preferred-name": {
                                "ce:given-name": "Daylia",
                                "ce:initials": "D.",
                                "ce:surname": "Thet",
                                "ce:indexed-name": "Thet D."
                            },
                            "@author-instance-id": "2005167463-d4f0a033db32f9c411e64a4be9761db0",
                            "@seq": "1",
                            "ce:initials": "D.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Thet",
                            "@auid": "57219293566",
                            "ce:indexed-name": "Thet D."
                        },
                        {
                            "ce:given-name": "Tippawan",
                            "preferred-name": {
                                "ce:given-name": "Tippawan",
                                "ce:initials": "T.",
                                "ce:surname": "Siritientong",
                                "ce:indexed-name": "Siritientong T."
                            },
                            "@author-instance-id": "2005167463-1a5d8b8ad5ab36fc220788b090851e95",
                            "@seq": "2",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Siritientong",
                            "@auid": "36474194400",
                            "ce:indexed-name": "Siritientong T."
                        }
                    ]
                },
                "citation-title": "Antiretroviral therapy-associated metabolic complications: Review of the recent studies",
                "abstracts": "© 2020 Thet and Siritientong.The extensive utilization of antiretroviral therapy (ART) has successfully improved human immunodeficiency virus (HIV)-associated complications. The incidence of opportunistic infections is decreased by the viral load suppression and the CD4 count promotion. However, metabolic complications, commonly bone demineralization, lipody-strophy, and lactic acidosis, are arising following the adaptation of long-term ART. The events are not drug-specific, but the severity and incidence individually vary depending upon classes of drugs. Such concerning occurrences may lead to discontinuation of current therapy or switching to another regimen with fewer adverse effects. The purpose of this review is to demonstrate the common metabolic abnormalities associated with each class of widely used ART in people living with HIV (PLHIV). Electronic databases such as PubMed, ScienceDirect, Scopus, Google Scholar, SciFinder, and Web of Science were used for the literature search. A better understanding of ART-associated metabolic adverse effects is helpful in various clinical settings so that therapists may optimize treatments in this population.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Food and Pharmaceutical Chemistry"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Department of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Tippawan",
                        "ce:initials": "T.",
                        "ce:surname": "Siritientong",
                        "ce:indexed-name": "Siritientong T."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Antiretroviral therapy",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "HIV",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Lipid profile",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Lipodystrophy",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Metabolic",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "re"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "HIV/AIDS - Res. Palliative Care",
                    "website": {"ce:e-address": {
                        "$": "https://www.dovepress.com/getfile.php?fileID=62074",
                        "@type": "email"
                    }},
                    "@country": "nzl",
                    "translated-sourcetitle": {
                        "$": "HIV/AIDS - Research and Palliative Care",
                        "@xml:lang": "eng"
                    },
                    "issn": {
                        "$": "11791373",
                        "@type": "electronic"
                    },
                    "volisspag": {
                        "voliss": {"@volume": "12"},
                        "pagerange": {
                            "@first": "507",
                            "@last": "524"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2020"},
                    "publisher": {"publishername": "Dove Medical Press Ltd"},
                    "sourcetitle": "HIV/AIDS - Research and Palliative Care",
                    "@srcid": "19700175786",
                    "publicationdate": {
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2020"
                        }
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "3",
                                    "classification-description": "Endocrinology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "4",
                                    "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"
                                },
                                {
                                    "classification-code": "6",
                                    "classification-description": "Internal Medicine"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2713"},
                                {"$": "2719"},
                                {"$": "2708"},
                                {"$": "2725"},
                                {"$": "2406"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "IMMU"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": [
                                    {"$": "136470-78-5"},
                                    {"$": "188062-50-2"}
                                ],
                                "chemical-name": "abacavir"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "9000-86-6"},
                                    {"$": "9014-30-6"}
                                ],
                                "enzyme-commission-number": "EC 2.6.1.2",
                                "chemical-name": "alanine aminotransferase"
                            },
                            {
                                "cas-registry-number": "9000-97-9",
                                "enzyme-commission-number": "EC 2.6.1.1",
                                "chemical-name": "aspartate aminotransferase"
                            },
                            {
                                "cas-registry-number": "198904-31-3",
                                "chemical-name": "atazanavir"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "206361-99-1"},
                                    {"$": "635728-49-3"}
                                ],
                                "chemical-name": "darunavir"
                            },
                            {
                                "cas-registry-number": "69655-05-6",
                                "chemical-name": "didanosine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "1051375-16-6"},
                                    {"$": "1051375-19-9"},
                                    {"$": "1172581-47-3"}
                                ],
                                "chemical-name": "dolutegravir"
                            },
                            {
                                "cas-registry-number": "154598-52-4",
                                "chemical-name": "efavirenz"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "137530-41-7"},
                                    {"$": "143491-54-7"},
                                    {"$": "143491-57-0"}
                                ],
                                "chemical-name": "emtricitabine"
                            },
                            {
                                "cas-registry-number": "269055-15-4",
                                "chemical-name": "etravirine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "150378-17-9"},
                                    {"$": "157810-81-6"},
                                    {"$": "180683-37-8"}
                                ],
                                "chemical-name": "indinavir"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "134678-17-4"},
                                    {"$": "134680-32-3"}
                                ],
                                "chemical-name": "lamivudine"
                            },
                            {
                                "cas-registry-number": "192725-17-0",
                                "chemical-name": "lopinavir"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "159989-64-7"},
                                    {"$": "159989-65-8"}
                                ],
                                "chemical-name": "nelfinavir"
                            },
                            {
                                "cas-registry-number": "129618-40-2",
                                "chemical-name": "nevirapine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "518048-05-0"},
                                    {"$": "871038-72-1"},
                                    {"$": "889131-29-7"}
                                ],
                                "chemical-name": "raltegravir"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "500287-72-9"},
                                    {"$": "700361-47-3"}
                                ],
                                "chemical-name": "rilpivirine"
                            },
                            {
                                "cas-registry-number": "155213-67-5",
                                "chemical-name": "ritonavir"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "127779-20-8"},
                                    {"$": "149845-06-7"}
                                ],
                                "chemical-name": "saquinavir"
                            },
                            {
                                "cas-registry-number": "3056-17-5",
                                "chemical-name": "stavudine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "379270-37-8"},
                                    {"$": "1392275-56-7"}
                                ],
                                "chemical-name": "tenofovir alafenamide"
                            },
                            {
                                "cas-registry-number": "202138-50-9",
                                "chemical-name": "tenofovir disoproxil"
                            },
                            {
                                "cas-registry-number": "30516-87-1",
                                "chemical-name": "zidovudine"
                            }
                        ]
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This review was supported by Thailand International Cooperation Agency Scholarship.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "26",
                    "@timestamp": "BST 13:04:22",
                    "@year": "2020",
                    "@month": "11"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2005167463",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "928830412",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200868772",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "2020401259",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20202371204",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2020386419",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20203556471",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2020000676062X",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85092104472",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85092104472",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.2147/HIV.S275314"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "57",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "UNAIDS. Global HIV & AIDS statistics_2020 fact sheet. 2020. Available from: https://www.unaids.org/en/resources/fact-sheet. Accessed July 24, 2020.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.unaids.org/en/resources/fact-sheet",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85088567098",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "UNAIDS. Accessed July 24, 2020",
                            "ref-sourcetitle": "Global HIV & AIDS statistics_2020 fact sheet"
                        },
                        "ce:source-text": "UNAIDS. Global HIV & AIDS statistics_2020 fact sheet. 2020. Available from: https://www.unaids.org/en/resources/fact-sheet. Accessed July 24, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810\u2013818. doi:10.1016/S1473-3099(15)00056-0",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Future challenges for clinical care of an ageing population infected with HIV: a modelling study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1473-3099(15)00056-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84937522755",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "810",
                                    "@last": "818"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Smit",
                                        "ce:indexed-name": "Smit M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Brinkman",
                                        "ce:indexed-name": "Brinkman K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Geerlings",
                                        "ce:indexed-name": "Geerlings S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Infect Dis"
                        },
                        "ce:source-text": "Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810\u2013818. doi:10.1016/S1473-3099(15)00056-0"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Poorolajal J, Hooshmand E, Mahjub H, Esmailnasab N, Jenabi E. Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis. Public Health. 2016;139:3\u201312. doi:10.1016/j. puhe.2016.05.004",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.puhe.2016.05.004",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84977501071",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "139"},
                                "pagerange": {
                                    "@first": "3",
                                    "@last": "12"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Poorolajal",
                                    "ce:indexed-name": "Poorolajal J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E",
                                    "@_fa": "true",
                                    "ce:surname": "Hooshmand",
                                    "ce:indexed-name": "Hooshmand E"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Mahjub",
                                    "ce:indexed-name": "Mahjub H"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Esmailnasab",
                                    "ce:indexed-name": "Esmailnasab N"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Jenabi",
                                    "ce:indexed-name": "Jenabi E."
                                }
                            ]},
                            "ref-sourcetitle": "Public Health"
                        },
                        "ce:source-text": "Poorolajal J, Hooshmand E, Mahjub H, Esmailnasab N, Jenabi E. Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis. Public Health. 2016;139:3\u201312. doi:10.1016/j. puhe.2016.05.004"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with antiretroviral therapy. Antiviral Res. 2001;51(3):151\u2013177. doi:10.1016/S0166-3542(01)00148-6",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Metabolic complications associated with antiretroviral therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0166-3542(01)00148-6",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0034934689",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "51",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "151",
                                    "@last": "177"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RG",
                                    "@_fa": "true",
                                    "ce:surname": "Jain",
                                    "ce:indexed-name": "Jain RG"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "ES",
                                    "@_fa": "true",
                                    "ce:surname": "Furfine",
                                    "ce:indexed-name": "Furfine ES"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Pedneault",
                                    "ce:indexed-name": "Pedneault L"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "AJ",
                                    "@_fa": "true",
                                    "ce:surname": "White",
                                    "ce:indexed-name": "White AJ"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "JM.",
                                    "@_fa": "true",
                                    "ce:surname": "Lenhard",
                                    "ce:indexed-name": "Lenhard JM."
                                }
                            ]},
                            "ref-sourcetitle": "Antiviral Res"
                        },
                        "ce:source-text": "Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with antiretroviral therapy. Antiviral Res. 2001;51(3):151\u2013177. doi:10.1016/S0166-3542(01)00148-6"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "World Health Organization. Update of recommendations on first-and second-line antiretroviral regimens. 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/325892/WHO-CDS-HIV-19.15-eng.pdf?ua=1. Accessed June 13, 2019.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://apps.who.int/iris/bitstream/handle/10665/325892/WHO-CDS-HIV-19.15-eng.pdf?ua=1",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85071760699",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "World Health Organization. Accessed June 13, 2019",
                            "ref-sourcetitle": "Update of recommendations on first-and second-line antiretroviral regimens"
                        },
                        "ce:source-text": "World Health Organization. Update of recommendations on first-and second-line antiretroviral regimens. 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/325892/WHO-CDS-HIV-19.15-eng.pdf?ua=1. Accessed June 13, 2019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20 (17):2165\u20132174. doi:10.1097/QAD.0b013e32801022eb",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/QAD.0b013e32801022eb",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "33750591177",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "17"
                                },
                                "pagerange": {
                                    "@first": "2165",
                                    "@last": "2174"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "TT",
                                    "@_fa": "true",
                                    "ce:surname": "Brown",
                                    "ce:indexed-name": "Brown TT"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "RB.",
                                    "@_fa": "true",
                                    "ce:surname": "Qaqish",
                                    "ce:indexed-name": "Qaqish RB."
                                }
                            ]},
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20 (17):2165\u20132174. doi:10.1097/QAD.0b013e32801022eb"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Walmsley S, Bernstein B, King M, et al. Lopinavir\u2013ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med. 2002;346(26):2039\u20132046. doi:10.1056/NEJMoa012354",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Lopinavir\u2013ritonavir versus nelfinavir for the initial treatment of HIV infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa012354",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0037182766",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "346",
                                    "@issue": "26"
                                },
                                "pagerange": {
                                    "@first": "2039",
                                    "@last": "2046"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Walmsley",
                                        "ce:indexed-name": "Walmsley S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Bernstein",
                                        "ce:indexed-name": "Bernstein B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "King",
                                        "ce:indexed-name": "King M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Walmsley S, Bernstein B, King M, et al. Lopinavir\u2013ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med. 2002;346(26):2039\u20132046. doi:10.1056/NEJMoa012354"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Dubé MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003;37(5):613\u2013627. doi:10.1086/378131",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1086/378131",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0042832397",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "37",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "613",
                                    "@last": "627"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MP",
                                        "@_fa": "true",
                                        "ce:surname": "Dubé",
                                        "ce:indexed-name": "Dube MP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JH",
                                        "@_fa": "true",
                                        "ce:surname": "Stein",
                                        "ce:indexed-name": "Stein JH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JA",
                                        "@_fa": "true",
                                        "ce:surname": "Aberg",
                                        "ce:indexed-name": "Aberg JA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Dubé MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003;37(5):613\u2013627. doi:10.1086/378131"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Guzman N, Vijayan V. HIV-Associated Lipodystrophy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493183/s. Accessed September 24, 2020.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ncbi.nlm.nih.gov/books/NBK493183/s",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "HIV-Associated Lipodystrophy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85075761998",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Accessed September 24, 2020",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Guzman",
                                    "ce:indexed-name": "Guzman N"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Vijayan",
                                    "ce:indexed-name": "Vijayan V."
                                }
                            ]}
                        },
                        "ce:source-text": "Guzman N, Vijayan V. HIV-Associated Lipodystrophy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493183/s. Accessed September 24, 2020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Fiorenza CG, Chou SH, Mantzoros CS. Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol. 2011;7 (3):137\u2013150. doi:10.1038/nrendo.2010.199",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Lipodystrophy: pathophysiology and advances in treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nrendo.2010.199",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "79952185204",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "137",
                                    "@last": "150"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "CG",
                                    "@_fa": "true",
                                    "ce:surname": "Fiorenza",
                                    "ce:indexed-name": "Fiorenza CG"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "SH",
                                    "@_fa": "true",
                                    "ce:surname": "Chou",
                                    "ce:indexed-name": "Chou SH"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "CS.",
                                    "@_fa": "true",
                                    "ce:surname": "Mantzoros",
                                    "ce:indexed-name": "Mantzoros CS."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Endocrinol"
                        },
                        "ce:source-text": "Fiorenza CG, Chou SH, Mantzoros CS. Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol. 2011;7 (3):137\u2013150. doi:10.1038/nrendo.2010.199"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Menezes CN, Maskew M, Sanne I, Crowther NJ, Raal FJ. A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects. BMC Infect Dis. 2011;11(1):244. doi:10.1186/1471-2334-11-244",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/1471-2334-11-244",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "80052842048",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "244"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "CN",
                                    "@_fa": "true",
                                    "ce:surname": "Menezes",
                                    "ce:indexed-name": "Menezes CN"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Maskew",
                                    "ce:indexed-name": "Maskew M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Sanne",
                                    "ce:indexed-name": "Sanne I"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "NJ",
                                    "@_fa": "true",
                                    "ce:surname": "Crowther",
                                    "ce:indexed-name": "Crowther NJ"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "FJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Raal",
                                    "ce:indexed-name": "Raal FJ."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Infect Dis"
                        },
                        "ce:source-text": "Menezes CN, Maskew M, Sanne I, Crowther NJ, Raal FJ. A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects. BMC Infect Dis. 2011;11(1):244. doi:10.1186/1471-2334-11-244"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Kim HR, Han MA. Association between serum liver enzymes and metabolic syndrome in Korean adults. Int J Environ Res Public Health. 2018;15(8):1658. doi:10.3390/ijerph15081658",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Association between serum liver enzymes and metabolic syndrome in Korean adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/ijerph15081658",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85051405168",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "8"
                                },
                                "pagerange": {"@first": "1658"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "HR",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim HR"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "MA.",
                                    "@_fa": "true",
                                    "ce:surname": "Han",
                                    "ce:indexed-name": "Han MA."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Environ Res Public Health"
                        },
                        "ce:source-text": "Kim HR, Han MA. Association between serum liver enzymes and metabolic syndrome in Korean adults. Int J Environ Res Public Health. 2018;15(8):1658. doi:10.3390/ijerph15081658"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Conradie M, van de Vyver M, Andrag E, Conradie M, Ferris W. A direct comparison of the effects of the antiretroviral drugs stavu-dine, tenofovir and the combination lopinavir/ritonavir on bone metabolism in a rat model. Calcif Tissue Int. 2017;101(4):422\u2013432. doi:10.1007/s00223-017-0290-3",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "A direct comparison of the effects of the antiretroviral drugs stavu-dine, tenofovir and the combination lopinavir/ritonavir on bone metabolism in a rat model"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00223-017-0290-3",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85019620118",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "101",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "422",
                                    "@last": "432"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Conradie",
                                    "ce:indexed-name": "Conradie M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "van de Vyver",
                                    "ce:indexed-name": "van de Vyver M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E",
                                    "@_fa": "true",
                                    "ce:surname": "Andrag",
                                    "ce:indexed-name": "Andrag E"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Conradie",
                                    "ce:indexed-name": "Conradie M"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Ferris",
                                    "ce:indexed-name": "Ferris W."
                                }
                            ]},
                            "ref-sourcetitle": "Calcif Tissue Int"
                        },
                        "ce:source-text": "Conradie M, van de Vyver M, Andrag E, Conradie M, Ferris W. A direct comparison of the effects of the antiretroviral drugs stavu-dine, tenofovir and the combination lopinavir/ritonavir on bone metabolism in a rat model. Calcif Tissue Int. 2017;101(4):422\u2013432. doi:10.1007/s00223-017-0290-3"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Pan G, Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM. AZT enhances osteoclastogenesis and bone loss. AIDS Res Hum Retroviruses. 2004;20(6):608\u2013620. doi:10.1089/0889222041217482",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "AZT enhances osteoclastogenesis and bone loss"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1089/0889222041217482",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "3042636307",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "608",
                                    "@last": "620"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Pan",
                                    "ce:indexed-name": "Pan G"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "X",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu X"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MA",
                                    "@_fa": "true",
                                    "ce:surname": "McKenna",
                                    "ce:indexed-name": "McKenna MA"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "X",
                                    "@_fa": "true",
                                    "ce:surname": "Feng",
                                    "ce:indexed-name": "Feng X"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "TR",
                                    "@_fa": "true",
                                    "ce:surname": "Nagy",
                                    "ce:indexed-name": "Nagy TR"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "JM.",
                                    "@_fa": "true",
                                    "ce:surname": "McDonald",
                                    "ce:indexed-name": "McDonald JM."
                                }
                            ]},
                            "ref-sourcetitle": "AIDS Res Hum Retroviruses"
                        },
                        "ce:source-text": "Pan G, Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM. AZT enhances osteoclastogenesis and bone loss. AIDS Res Hum Retroviruses. 2004;20(6):608\u2013620. doi:10.1089/0889222041217482"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Pistell PJ, Gupta S, Knight AG, et al. Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice. Antiviral Res. 2010;88(3):334\u2013342. doi:10.1016/j. antiviral.2010.10.006",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.antiviral.2010.10.006",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "78650254451",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "88",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "334",
                                    "@last": "342"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PJ",
                                        "@_fa": "true",
                                        "ce:surname": "Pistell",
                                        "ce:indexed-name": "Pistell PJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Gupta",
                                        "ce:indexed-name": "Gupta S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AG",
                                        "@_fa": "true",
                                        "ce:surname": "Knight",
                                        "ce:indexed-name": "Knight AG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antiviral Res"
                        },
                        "ce:source-text": "Pistell PJ, Gupta S, Knight AG, et al. Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice. Antiviral Res. 2010;88(3):334\u2013342. doi:10.1016/j. antiviral.2010.10.006"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Tsai F-J, Ho M-W, Lai C-H, et al. Evaluation of oral antiretroviral drugs in mice with metabolic and neurologic complications. Front Pharmacol. 2018;9:1004. doi:10.3389/fphar.2018.01004",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Evaluation of oral antiretroviral drugs in mice with metabolic and neurologic complications"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fphar.2018.01004",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85053162081",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "1004"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F-J",
                                        "@_fa": "true",
                                        "ce:surname": "Tsai",
                                        "ce:indexed-name": "Tsai F-J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M-W",
                                        "@_fa": "true",
                                        "ce:surname": "Ho",
                                        "ce:indexed-name": "Ho M-W"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C-H",
                                        "@_fa": "true",
                                        "ce:surname": "Lai",
                                        "ce:indexed-name": "Lai C-H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Pharmacol"
                        },
                        "ce:source-text": "Tsai F-J, Ho M-W, Lai C-H, et al. Evaluation of oral antiretroviral drugs in mice with metabolic and neurologic complications. Front Pharmacol. 2018;9:1004. doi:10.3389/fphar.2018.01004"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Sembongi H, Miranda M, Han G-S, et al. Distinct roles of the phosphatidate phosphatases lipin 1 and 2 during adipogenesis and lipid droplet biogenesis in 3T3-L1 cells. J Biol Chem. 2013;288 (48):34502\u201334513. doi:10.1074/jbc.M113.488445",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Distinct roles of the phosphatidate phosphatases lipin 1 and 2 during adipogenesis and lipid droplet biogenesis in 3T3-L1 cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1074/jbc.M113.488445",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84889040528",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "288",
                                    "@issue": "48"
                                },
                                "pagerange": {
                                    "@first": "34502",
                                    "@last": "34513"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Sembongi",
                                        "ce:indexed-name": "Sembongi H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Miranda",
                                        "ce:indexed-name": "Miranda M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G-S",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han G-S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Biol Chem"
                        },
                        "ce:source-text": "Sembongi H, Miranda M, Han G-S, et al. Distinct roles of the phosphatidate phosphatases lipin 1 and 2 during adipogenesis and lipid droplet biogenesis in 3T3-L1 cells. J Biol Chem. 2013;288 (48):34502\u201334513. doi:10.1074/jbc.M113.488445"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Bresciani E, Saletti C, Squillace N, et al. miRNA-218 targets Lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/itonavir. Front Pharmacol. 2019;10(461). doi:10.3389/fphar.2019.00461",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "miRNA-218 targets Lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/itonavir"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fphar.2019.00461",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85068467208",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "10",
                                "@issue": "461"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Bresciani",
                                        "ce:indexed-name": "Bresciani E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Saletti",
                                        "ce:indexed-name": "Saletti C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Squillace",
                                        "ce:indexed-name": "Squillace N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Pharmacol"
                        },
                        "ce:source-text": "Bresciani E, Saletti C, Squillace N, et al. miRNA-218 targets Lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/itonavir. Front Pharmacol. 2019;10(461). doi:10.3389/fphar.2019.00461"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Caron M, Auclair M, Lagathu C, et al. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. AIDS. 2004;18(16):2127\u20132136. doi:10.1097/00002030-200411050-00004",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/00002030-200411050-00004",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "7744223038",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "2127",
                                    "@last": "2136"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Caron",
                                        "ce:indexed-name": "Caron M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Auclair",
                                        "ce:indexed-name": "Auclair M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Lagathu",
                                        "ce:indexed-name": "Lagathu C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Caron M, Auclair M, Lagathu C, et al. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. AIDS. 2004;18(16):2127\u20132136. doi:10.1097/00002030-200411050-00004"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Nolan D, Hammond E, Martin A, et al. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS. 2003;17(9):1329\u20131338. doi:10.1097/00002030-200306130-00007",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/00002030-200306130-00007",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0037999080",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1329",
                                    "@last": "1338"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Nolan",
                                        "ce:indexed-name": "Nolan D"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Hammond",
                                        "ce:indexed-name": "Hammond E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Martin",
                                        "ce:indexed-name": "Martin A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Nolan D, Hammond E, Martin A, et al. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS. 2003;17(9):1329\u20131338. doi:10.1097/00002030-200306130-00007"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Tarr PE, Taffé P, Bleiber G, et al. Modeling the influence of APOC3, APOE and TNF polymorphisms on the risk of antiretroviral therapy\u2013 associated lipid disorders. J Infect Dis. 2005;191(9):1419\u20131426. doi:10.1086/430627",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Modeling the influence of APOC3, APOE and TNF polymorphisms on the risk of antiretroviral therapy\u2013 associated lipid disorders"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1086/430627",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "21044442371",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "191",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1419",
                                    "@last": "1426"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PE",
                                        "@_fa": "true",
                                        "ce:surname": "Tarr",
                                        "ce:indexed-name": "Tarr PE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Taffé",
                                        "ce:indexed-name": "Taffe P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Bleiber",
                                        "ce:indexed-name": "Bleiber G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Infect Dis"
                        },
                        "ce:source-text": "Tarr PE, Taffé P, Bleiber G, et al. Modeling the influence of APOC3, APOE and TNF polymorphisms on the risk of antiretroviral therapy\u2013 associated lipid disorders. J Infect Dis. 2005;191(9):1419\u20131426. doi:10.1086/430627"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Fauvel J, Bonnet E, Ruidavets J-B, et al. An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/ low HDL levels in treated HIV patients. AIDS. 2001;15 (18):2397\u20132406. doi:10.1097/00002030-200112070-00007",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/ low HDL levels in treated HIV patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/00002030-200112070-00007",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0035824763",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "18"
                                },
                                "pagerange": {
                                    "@first": "2397",
                                    "@last": "2406"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Fauvel",
                                        "ce:indexed-name": "Fauvel J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Bonnet",
                                        "ce:indexed-name": "Bonnet E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J-B",
                                        "@_fa": "true",
                                        "ce:surname": "Ruidavets",
                                        "ce:indexed-name": "Ruidavets J-B"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Fauvel J, Bonnet E, Ruidavets J-B, et al. An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/ low HDL levels in treated HIV patients. AIDS. 2001;15 (18):2397\u20132406. doi:10.1097/00002030-200112070-00007"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Curtis JR, Smith B, Weaver M, et al. Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy. AIDS Res Hum Retroviruses. 2006;22(2):125\u2013131. doi:10.1089/aid.2006.22.125",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1089/aid.2006.22.125",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "33244462660",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "125",
                                    "@last": "131"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JR",
                                        "@_fa": "true",
                                        "ce:surname": "Curtis",
                                        "ce:indexed-name": "Curtis JR"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Smith",
                                        "ce:indexed-name": "Smith B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Weaver",
                                        "ce:indexed-name": "Weaver M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS Res Hum Retroviruses"
                        },
                        "ce:source-text": "Curtis JR, Smith B, Weaver M, et al. Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy. AIDS Res Hum Retroviruses. 2006;22(2):125\u2013131. doi:10.1089/aid.2006.22.125"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Misra R, Chandra P, Riechman SE, et al. Relationship of ethnicity and CD4 count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART). BMC Endocr Disord. 2013;13(1):13. doi:10.1186/1472-6823-13-13",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Relationship of ethnicity and CD4 count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/1472-6823-13-13",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84876735195",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "13"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Misra",
                                        "ce:indexed-name": "Misra R"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Chandra",
                                        "ce:indexed-name": "Chandra P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SE",
                                        "@_fa": "true",
                                        "ce:surname": "Riechman",
                                        "ce:indexed-name": "Riechman SE"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Endocr Disord"
                        },
                        "ce:source-text": "Misra R, Chandra P, Riechman SE, et al. Relationship of ethnicity and CD4 count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART). BMC Endocr Disord. 2013;13(1):13. doi:10.1186/1472-6823-13-13"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Mallal SA, John M, Moore CB, James IR, McKinnon EJ. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS. 2000;14(10):1309\u20131316. doi:10.1097/00002030-200007070-00002",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/00002030-200007070-00002",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0033924871",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1309",
                                    "@last": "1316"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "SA",
                                    "@_fa": "true",
                                    "ce:surname": "Mallal",
                                    "ce:indexed-name": "Mallal SA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "John",
                                    "ce:indexed-name": "John M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "CB",
                                    "@_fa": "true",
                                    "ce:surname": "Moore",
                                    "ce:indexed-name": "Moore CB"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "IR",
                                    "@_fa": "true",
                                    "ce:surname": "James",
                                    "ce:indexed-name": "James IR"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "EJ.",
                                    "@_fa": "true",
                                    "ce:surname": "McKinnon",
                                    "ce:indexed-name": "McKinnon EJ."
                                }
                            ]},
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Mallal SA, John M, Moore CB, James IR, McKinnon EJ. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS. 2000;14(10):1309\u20131316. doi:10.1097/00002030-200007070-00002"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Foulkes AS, Wohl DA, Frank I, et al. Associations among race/ ethnicity, apoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. PLoS Med. 2006;3(3):337\u2013347. doi:10.1371/journal.pmed.0030052",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Associations among race/ ethnicity, apoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pmed.0030052",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "33645329876",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "337",
                                    "@last": "347"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AS",
                                        "@_fa": "true",
                                        "ce:surname": "Foulkes",
                                        "ce:indexed-name": "Foulkes AS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DA",
                                        "@_fa": "true",
                                        "ce:surname": "Wohl",
                                        "ce:indexed-name": "Wohl DA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Frank",
                                        "ce:indexed-name": "Frank I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS Med"
                        },
                        "ce:source-text": "Foulkes AS, Wohl DA, Frank I, et al. Associations among race/ ethnicity, apoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. PLoS Med. 2006;3(3):337\u2013347. doi:10.1371/journal.pmed.0030052"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Mills A, Arribas JR, Andrade-Villanueva J, et al. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretro-viral regimens for virologically suppressed adults with HIV-1 infec-tion: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. Lancet Infect Dis. 2016;16(1):43\u201352. doi:10.1016/S1473-3099(15)00348-5",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretro-viral regimens for virologically suppressed adults with HIV-1 infec-tion: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1473-3099(15)00348-5",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85028245571",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "43",
                                    "@last": "52"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Mills",
                                        "ce:indexed-name": "Mills A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JR",
                                        "@_fa": "true",
                                        "ce:surname": "Arribas",
                                        "ce:indexed-name": "Arribas JR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Andrade-Villanueva",
                                        "ce:indexed-name": "Andrade-Villanueva J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Infect Dis"
                        },
                        "ce:source-text": "Mills A, Arribas JR, Andrade-Villanueva J, et al. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretro-viral regimens for virologically suppressed adults with HIV-1 infec-tion: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. Lancet Infect Dis. 2016;16(1):43\u201352. doi:10.1016/S1473-3099(15)00348-5"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Joly V, Flandre P, Meiffredy V, et al. Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS. 2002;16(18):2447\u20132454. doi:10.1097/00002030-200212060-00010",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/00002030-200212060-00010",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0037032941",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "18"
                                },
                                "pagerange": {
                                    "@first": "2447",
                                    "@last": "2454"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Joly",
                                        "ce:indexed-name": "Joly V"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Flandre",
                                        "ce:indexed-name": "Flandre P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Meiffredy",
                                        "ce:indexed-name": "Meiffredy V"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Joly V, Flandre P, Meiffredy V, et al. Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS. 2002;16(18):2447\u20132454. doi:10.1097/00002030-200212060-00010"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Alikhani A, Morin H, Matte S, Alikhani P, Tremblay C, Durand M. Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal. BMC Infect Dis. 2019;19(1):820. doi:10.1186/s12879-019-4446-9",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s12879-019-4446-9",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85072376794",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "820"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Alikhani",
                                    "ce:indexed-name": "Alikhani A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Morin",
                                    "ce:indexed-name": "Morin H"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Matte",
                                    "ce:indexed-name": "Matte S"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Alikhani",
                                    "ce:indexed-name": "Alikhani P"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Tremblay",
                                    "ce:indexed-name": "Tremblay C"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Durand",
                                    "ce:indexed-name": "Durand M."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Infect Dis"
                        },
                        "ce:source-text": "Alikhani A, Morin H, Matte S, Alikhani P, Tremblay C, Durand M. Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal. BMC Infect Dis. 2019;19(1):820. doi:10.1186/s12879-019-4446-9"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Gallant JE, Staszewski S, Pozniak AL, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292(2):191\u2013201. doi:10.1001/jama.292.2.191",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1001/jama.292.2.191",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "3042848853",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "292",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "191",
                                    "@last": "201"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JE",
                                        "@_fa": "true",
                                        "ce:surname": "Gallant",
                                        "ce:indexed-name": "Gallant JE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Staszewski",
                                        "ce:indexed-name": "Staszewski S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AL",
                                        "@_fa": "true",
                                        "ce:surname": "Pozniak",
                                        "ce:indexed-name": "Pozniak AL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA"
                        },
                        "ce:source-text": "Gallant JE, Staszewski S, Pozniak AL, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292(2):191\u2013201. doi:10.1001/jama.292.2.191"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Haubrich RH, Riddler SA, DiRienzo AG, et al. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 2009;23 (9):1109. doi:10.1097/QAD.0b013e32832b4377",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/QAD.0b013e32832b4377",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "67651096095",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "9"
                                },
                                "pagerange": {"@first": "1109"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RH",
                                        "@_fa": "true",
                                        "ce:surname": "Haubrich",
                                        "ce:indexed-name": "Haubrich RH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Riddler",
                                        "ce:indexed-name": "Riddler SA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AG",
                                        "@_fa": "true",
                                        "ce:surname": "DiRienzo",
                                        "ce:indexed-name": "DiRienzo AG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Haubrich RH, Riddler SA, DiRienzo AG, et al. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 2009;23 (9):1109. doi:10.1097/QAD.0b013e32832b4377"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Gallant JE, DeJesus E, Arribas JR, et al. Tenofovir DF, emtricita-bine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med. 2006;354(3):251\u2013260. doi:10.1056/NEJMoa051871",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Tenofovir DF, emtricita-bine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa051871",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "30944468562",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "354",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "251",
                                    "@last": "260"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JE",
                                        "@_fa": "true",
                                        "ce:surname": "Gallant",
                                        "ce:indexed-name": "Gallant JE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "DeJesus",
                                        "ce:indexed-name": "DeJesus E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JR",
                                        "@_fa": "true",
                                        "ce:surname": "Arribas",
                                        "ce:indexed-name": "Arribas JR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Gallant JE, DeJesus E, Arribas JR, et al. Tenofovir DF, emtricita-bine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med. 2006;354(3):251\u2013260. doi:10.1056/NEJMoa051871"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Dube MP, Parker RA, Tebas P, et al. Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfi-navir or efavirenz plus dual nucleosides. AIDS. 2005;19 (16):1807\u20131818. doi:10.1097/01.aids.0000183629.20041.bb",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfi-navir or efavirenz plus dual nucleosides"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/01.aids.0000183629.20041.bb",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "26844543445",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "1807",
                                    "@last": "1818"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MP",
                                        "@_fa": "true",
                                        "ce:surname": "Dube",
                                        "ce:indexed-name": "Dube MP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RA",
                                        "@_fa": "true",
                                        "ce:surname": "Parker",
                                        "ce:indexed-name": "Parker RA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Tebas",
                                        "ce:indexed-name": "Tebas P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Dube MP, Parker RA, Tebas P, et al. Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfi-navir or efavirenz plus dual nucleosides. AIDS. 2005;19 (16):1807\u20131818. doi:10.1097/01.aids.0000183629.20041.bb"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Martin A, Bloch M, Amin J, et al. Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: a randomized, 96-week trial. Clin Infect Dis. 2009;49(10):1591\u20131601. doi:10.1086/644769",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: a randomized, 96-week trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1086/644769",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "72849149643",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "49",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1591",
                                    "@last": "1601"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Martin",
                                        "ce:indexed-name": "Martin A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Bloch",
                                        "ce:indexed-name": "Bloch M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Amin",
                                        "ce:indexed-name": "Amin J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Martin A, Bloch M, Amin J, et al. Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: a randomized, 96-week trial. Clin Infect Dis. 2009;49(10):1591\u20131601. doi:10.1086/644769"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Sax PE, Wohl D, Yin MT, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobi-cistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, Phase 3, non-inferiority trials. Lancet. 2015;385(9987):2606\u20132615. doi:10.1016/S0140-6736(15) 60616-X",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobi-cistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, Phase 3, non-inferiority trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(15)60616-X",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84937215233",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "385",
                                    "@issue": "9987"
                                },
                                "pagerange": {
                                    "@first": "2606",
                                    "@last": "2615"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PE",
                                        "@_fa": "true",
                                        "ce:surname": "Sax",
                                        "ce:indexed-name": "Sax PE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Wohl",
                                        "ce:indexed-name": "Wohl D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MT",
                                        "@_fa": "true",
                                        "ce:surname": "Yin",
                                        "ce:indexed-name": "Yin MT"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Sax PE, Wohl D, Yin MT, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobi-cistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, Phase 3, non-inferiority trials. Lancet. 2015;385(9987):2606\u20132615. doi:10.1016/S0140-6736(15) 60616-X"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Chen J, Chen R, Shen Y, et al. Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trial. Emerg Microbes Infect. 2020;9(s1):843\u2013850. doi:10.1080/22221751.2020.1752609",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/22221751.2020.1752609",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85084271205",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "s1"
                                },
                                "pagerange": {
                                    "@first": "843",
                                    "@last": "850"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Shen",
                                        "ce:indexed-name": "Shen Y"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Emerg Microbes Infect"
                        },
                        "ce:source-text": "Chen J, Chen R, Shen Y, et al. Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trial. Emerg Microbes Infect. 2020;9(s1):843\u2013850. doi:10.1080/22221751.2020.1752609"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Martínez E, Arnaiz JA, Podzamczer D, et al. Substitution of nevir-apine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. N Engl J Med. 2003;349 (11):1036\u20131046. doi:10.1056/NEJMoa021589",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Substitution of nevir-apine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa021589",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0042387870",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "349",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1036",
                                    "@last": "1046"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Martínez",
                                        "ce:indexed-name": "Martinez E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JA",
                                        "@_fa": "true",
                                        "ce:surname": "Arnaiz",
                                        "ce:indexed-name": "Arnaiz JA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Podzamczer",
                                        "ce:indexed-name": "Podzamczer D"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Martínez E, Arnaiz JA, Podzamczer D, et al. Substitution of nevir-apine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. N Engl J Med. 2003;349 (11):1036\u20131046. doi:10.1056/NEJMoa021589"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Cohen CJ, Molina J-M, Cassetti I, et al. Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials. AIDS. 2013;27(6):939\u2013950. doi:10.1097/QAD.0b 013e32835cee6e",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/QAD.0b013e32835cee6e",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84876406278",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "939",
                                    "@last": "950"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CJ",
                                        "@_fa": "true",
                                        "ce:surname": "Cohen",
                                        "ce:indexed-name": "Cohen CJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J-M",
                                        "@_fa": "true",
                                        "ce:surname": "Molina",
                                        "ce:indexed-name": "Molina J-M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Cassetti",
                                        "ce:indexed-name": "Cassetti I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Cohen CJ, Molina J-M, Cassetti I, et al. Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials. AIDS. 2013;27(6):939\u2013950. doi:10.1097/QAD.0b 013e32835cee6e"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Lazzarin A, Campbell T, Clotet B, et al. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial. Lancet. 2007;370 (9581):39\u201348. doi:10.1016/S0140-6736(07)61048-4",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(07)61048-4",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "34347354196",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "370",
                                    "@issue": "9581"
                                },
                                "pagerange": {
                                    "@first": "39",
                                    "@last": "48"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Lazzarin",
                                        "ce:indexed-name": "Lazzarin A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Campbell",
                                        "ce:indexed-name": "Campbell T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Clotet",
                                        "ce:indexed-name": "Clotet B"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Lazzarin A, Campbell T, Clotet B, et al. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial. Lancet. 2007;370 (9581):39\u201348. doi:10.1016/S0140-6736(07)61048-4"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Fätkenheuer G, Duvivier C, Rieger A, et al. Lipid profiles for etra-virine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial. J Antimicrob Chemother. 2012;67 (3):685\u2013690. doi:10.1093/jac/dkr533",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Lipid profiles for etra-virine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/jac/dkr533",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84863393499",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "67",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "685",
                                    "@last": "690"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Fätkenheuer",
                                        "ce:indexed-name": "Fatkenheuer G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Duvivier",
                                        "ce:indexed-name": "Duvivier C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Rieger",
                                        "ce:indexed-name": "Rieger A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Fätkenheuer G, Duvivier C, Rieger A, et al. Lipid profiles for etra-virine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial. J Antimicrob Chemother. 2012;67 (3):685\u2013690. doi:10.1093/jac/dkr533"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Shlay JC, Bartsch G, Peng G, et al. Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy. J Acquir Immune Defic Syndr. 2007;44 (5):506\u2013517. doi:10.1097/QAI.0b013e31804216cf",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/QAI.0b013e31804216cf",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "34247148867",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "44",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "506",
                                    "@last": "517"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JC",
                                        "@_fa": "true",
                                        "ce:surname": "Shlay",
                                        "ce:indexed-name": "Shlay JC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Bartsch",
                                        "ce:indexed-name": "Bartsch G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Peng",
                                        "ce:indexed-name": "Peng G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Shlay JC, Bartsch G, Peng G, et al. Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy. J Acquir Immune Defic Syndr. 2007;44 (5):506\u2013517. doi:10.1097/QAI.0b013e31804216cf"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Arathoon E, Schneider S, Baraldi E, et al. Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naïve HIV-1-infected patients at week 96: ARTEMIS. Int J STD AIDS. 2013;24(1). doi:10.1258/ijsa. 2012.012120",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naïve HIV-1-infected patients at week 96: ARTEMIS"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1258/ijsa.2012.012120",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84879472944",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "24",
                                "@issue": "1"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Arathoon",
                                        "ce:indexed-name": "Arathoon E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Schneider",
                                        "ce:indexed-name": "Schneider S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Baraldi",
                                        "ce:indexed-name": "Baraldi E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J STD AIDS"
                        },
                        "ce:source-text": "Arathoon E, Schneider S, Baraldi E, et al. Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naïve HIV-1-infected patients at week 96: ARTEMIS. Int J STD AIDS. 2013;24(1). doi:10.1258/ijsa. 2012.012120"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Clumeck N, Goebel F, Rozenbaum W, et al. Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA. AIDS. 2001;15 (12):1517\u20131526. doi:10.1097/00002030-200108170-00009",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/00002030-200108170-00009",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0035902939",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1517",
                                    "@last": "1526"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Clumeck",
                                        "ce:indexed-name": "Clumeck N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Goebel",
                                        "ce:indexed-name": "Goebel F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Rozenbaum",
                                        "ce:indexed-name": "Rozenbaum W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Clumeck N, Goebel F, Rozenbaum W, et al. Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA. AIDS. 2001;15 (12):1517\u20131526. doi:10.1097/00002030-200108170-00009"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Ortiz R, DeJesus E, Khanlou H, et al. Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48. AIDS. 2008;22 (12):1389\u20131397. doi:10.1097/QAD.0b013e32830285fb",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/QAD.0b013e32830285fb",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "49649092719",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1389",
                                    "@last": "1397"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Ortiz",
                                        "ce:indexed-name": "Ortiz R"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "DeJesus",
                                        "ce:indexed-name": "DeJesus E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Khanlou",
                                        "ce:indexed-name": "Khanlou H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Ortiz R, DeJesus E, Khanlou H, et al. Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48. AIDS. 2008;22 (12):1389\u20131397. doi:10.1097/QAD.0b013e32830285fb"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Madruga JV, Berger D, McMurchie M, et al. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial. Lancet. 2007;370 (9581):49\u201358. doi:10.1016/S0140-6736(07)61049-6",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(07)61049-6",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "34347329093",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "370",
                                    "@issue": "9581"
                                },
                                "pagerange": {
                                    "@first": "49",
                                    "@last": "58"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JV",
                                        "@_fa": "true",
                                        "ce:surname": "Madruga",
                                        "ce:indexed-name": "Madruga JV"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Berger",
                                        "ce:indexed-name": "Berger D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "McMurchie",
                                        "ce:indexed-name": "McMurchie M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Madruga JV, Berger D, McMurchie M, et al. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial. Lancet. 2007;370 (9581):49\u201358. doi:10.1016/S0140-6736(07)61049-6"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Molina J-M, Andrade-Villanueva J, Echevarria J, et al. Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study. J Acquir Immune Defic Syndr. 2010;53(3):323\u2013332. doi:10.1097/QAI.0b013e3181c990bf",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/QAI.0b013e3181c990bf",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "77649201378",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "53",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "323",
                                    "@last": "332"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J-M",
                                        "@_fa": "true",
                                        "ce:surname": "Molina",
                                        "ce:indexed-name": "Molina J-M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Andrade-Villanueva",
                                        "ce:indexed-name": "Andrade-Villanueva J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Echevarria",
                                        "ce:indexed-name": "Echevarria J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Molina J-M, Andrade-Villanueva J, Echevarria J, et al. Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study. J Acquir Immune Defic Syndr. 2010;53(3):323\u2013332. doi:10.1097/QAI.0b013e3181c990bf"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Dirajlal-Fargo S, Moser C, Brown TT, et al. Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infect Dis. 2016;3(3):ofw174. doi:10.1093/ofid/ofw174",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS Clinical Trials Group A5260s"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/ofid/ofw174",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85045325822",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "ofw174"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Dirajlal-Fargo",
                                        "ce:indexed-name": "Dirajlal-Fargo S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Moser",
                                        "ce:indexed-name": "Moser C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "TT",
                                        "@_fa": "true",
                                        "ce:surname": "Brown",
                                        "ce:indexed-name": "Brown TT"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Open Forum Infect Dis"
                        },
                        "ce:source-text": "Dirajlal-Fargo S, Moser C, Brown TT, et al. Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infect Dis. 2016;3(3):ofw174. doi:10.1093/ofid/ofw174"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Duvivier C, Kolta S, Assoumou L, et al. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. AIDS. 2009;23(7):817\u2013824. doi:10.1097/QAD.0b013e328328f789",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/QAD.0b013e328328f789",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "67649639637",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "817",
                                    "@last": "824"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Duvivier",
                                        "ce:indexed-name": "Duvivier C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Kolta",
                                        "ce:indexed-name": "Kolta S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Assoumou",
                                        "ce:indexed-name": "Assoumou L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Duvivier C, Kolta S, Assoumou L, et al. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. AIDS. 2009;23(7):817\u2013824. doi:10.1097/QAD.0b013e328328f789"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Lennox JL, DeJesus E, Lazzarin A, et al. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. Lancet. 2009;374 (9692):796\u2013806. doi:10.1016/S0140-6736(09)60918-1",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(09)60918-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "69449101785",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "374",
                                    "@issue": "9692"
                                },
                                "pagerange": {
                                    "@first": "796",
                                    "@last": "806"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JL",
                                        "@_fa": "true",
                                        "ce:surname": "Lennox",
                                        "ce:indexed-name": "Lennox JL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "DeJesus",
                                        "ce:indexed-name": "DeJesus E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Lazzarin",
                                        "ce:indexed-name": "Lazzarin A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Lennox JL, DeJesus E, Lazzarin A, et al. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. Lancet. 2009;374 (9692):796\u2013806. doi:10.1016/S0140-6736(09)60918-1"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Elzi L, Erb S, Furrer H, et al. Adverse events of raltegravir and dolutegravir. AIDS. 2017;31(13):1853. doi:10.1097/QAD.0000000 000001590",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Adverse events of raltegravir and dolutegravir"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/QAD.0000000000001590",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85022187047",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "31",
                                    "@issue": "13"
                                },
                                "pagerange": {"@first": "1853"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Elzi",
                                        "ce:indexed-name": "Elzi L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Erb",
                                        "ce:indexed-name": "Erb S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Furrer",
                                        "ce:indexed-name": "Furrer H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Elzi L, Erb S, Furrer H, et al. Adverse events of raltegravir and dolutegravir. AIDS. 2017;31(13):1853. doi:10.1097/QAD.0000000 000001590"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Tebas P, Zhang J, Yarasheski K, et al. Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s). J Acquir Immune Defic Syndr. 2007;45(2):193. doi:10.1097/QAI.0b013e318042e204",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/QAI.0b013e318042e204",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "34249885090",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "45",
                                    "@issue": "2"
                                },
                                "pagerange": {"@first": "193"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Tebas",
                                        "ce:indexed-name": "Tebas P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Yarasheski",
                                        "ce:indexed-name": "Yarasheski K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Tebas P, Zhang J, Yarasheski K, et al. Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s). J Acquir Immune Defic Syndr. 2007;45(2):193. doi:10.1097/QAI.0b013e318042e204"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Perez-Molina J, Rubio R, Rivero A, et al. Simplification to dual therapy (atazanavir/ritonavir+ lamivudine) versus standard triple therapy [atazanavir/ritonavir+ two nucleos (t) ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study). J Antimicrob Chemother. 2016;72(1):246\u2013253. doi:10.1093/jac/dkw379",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Simplification to dual therapy (atazanavir/ritonavir+ lamivudine) versus standard triple therapy [atazanavir/ritonavir+ two nucleos (t) ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/jac/dkw379",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85014524969",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "72",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "246",
                                    "@last": "253"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Perez-Molina",
                                        "ce:indexed-name": "Perez-Molina J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Rubio",
                                        "ce:indexed-name": "Rubio R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Rivero",
                                        "ce:indexed-name": "Rivero A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Perez-Molina J, Rubio R, Rivero A, et al. Simplification to dual therapy (atazanavir/ritonavir+ lamivudine) versus standard triple therapy [atazanavir/ritonavir+ two nucleos (t) ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study). J Antimicrob Chemother. 2016;72(1):246\u2013253. doi:10.1093/jac/dkw379"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Carr A, Workman C, Smith DE, et al. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA. 2002;288(2):207\u2013215. doi:10.1001/jama.288.2.207",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1001/jama.288.2.207",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0037055028",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "288",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "207",
                                    "@last": "215"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Carr",
                                        "ce:indexed-name": "Carr A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Workman",
                                        "ce:indexed-name": "Workman C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DE",
                                        "@_fa": "true",
                                        "ce:surname": "Smith",
                                        "ce:indexed-name": "Smith DE"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA"
                        },
                        "ce:source-text": "Carr A, Workman C, Smith DE, et al. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA. 2002;288(2):207\u2013215. doi:10.1001/jama.288.2.207"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Busti AJ, Bedimo R, Margolis DM, Hardin DS. Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir. J Investig Med. 2008;56(2):539\u2013544. doi:10.2310/JIM.0b013e3181641b26",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2310/JIM.0b013e3181641b26",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85047681377",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "56",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "539",
                                    "@last": "544"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AJ",
                                    "@_fa": "true",
                                    "ce:surname": "Busti",
                                    "ce:indexed-name": "Busti AJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Bedimo",
                                    "ce:indexed-name": "Bedimo R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "DM",
                                    "@_fa": "true",
                                    "ce:surname": "Margolis",
                                    "ce:indexed-name": "Margolis DM"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "DS.",
                                    "@_fa": "true",
                                    "ce:surname": "Hardin",
                                    "ce:indexed-name": "Hardin DS."
                                }
                            ]},
                            "ref-sourcetitle": "J Investig Med"
                        },
                        "ce:source-text": "Busti AJ, Bedimo R, Margolis DM, Hardin DS. Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir. J Investig Med. 2008;56(2):539\u2013544. doi:10.2310/JIM.0b013e3181641b26"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Maggiolo F, Rizzardini G, Raffi F, et al. Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, rando-mised trial. Lancet HIV. 2019;6(10):e655\u2013e666. doi:10.1016/S2352-3018(19)30195-X",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, rando-mised trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S2352-3018(19)30195-X",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85072679420",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "6",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "e655",
                                    "@last": "e666"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Maggiolo",
                                        "ce:indexed-name": "Maggiolo F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Rizzardini",
                                        "ce:indexed-name": "Rizzardini G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Raffi",
                                        "ce:indexed-name": "Raffi F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet HIV"
                        },
                        "ce:source-text": "Maggiolo F, Rizzardini G, Raffi F, et al. Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, rando-mised trial. Lancet HIV. 2019;6(10):e655\u2013e666. doi:10.1016/S2352-3018(19)30195-X"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Tetteh RA, Nartey ET, Lartey M, et al. Association between the occurrence of adverse drug events and modification of first-line highly active antiretroviral therapy in Ghanaian HIV patients. Drug Saf. 2016;39(11):1139\u20131149. doi:10.1007/s40264-016-0460-7",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Association between the occurrence of adverse drug events and modification of first-line highly active antiretroviral therapy in Ghanaian HIV patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s40264-016-0460-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84988345089",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "39",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1139",
                                    "@last": "1149"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RA",
                                        "@_fa": "true",
                                        "ce:surname": "Tetteh",
                                        "ce:indexed-name": "Tetteh RA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "ET",
                                        "@_fa": "true",
                                        "ce:surname": "Nartey",
                                        "ce:indexed-name": "Nartey ET"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lartey",
                                        "ce:indexed-name": "Lartey M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Saf"
                        },
                        "ce:source-text": "Tetteh RA, Nartey ET, Lartey M, et al. Association between the occurrence of adverse drug events and modification of first-line highly active antiretroviral therapy in Ghanaian HIV patients. Drug Saf. 2016;39(11):1139\u20131149. doi:10.1007/s40264-016-0460-7"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.128",
                        "ref-fulltext": "Clark WA, Cress EM. Nutritional issues and positive living in human immunodeficiency virus/AIDS. Nurs Clin. 2018;53(1):13\u201324. doi:10.1016/j.cnur.2017.10.002",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Nutritional issues and positive living in human immunodeficiency virus/AIDS"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.cnur.2017.10.002",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85041360429",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "53",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "13",
                                    "@last": "24"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "WA",
                                    "@_fa": "true",
                                    "ce:surname": "Clark",
                                    "ce:indexed-name": "Clark WA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "EM.",
                                    "@_fa": "true",
                                    "ce:surname": "Cress",
                                    "ce:indexed-name": "Cress EM."
                                }
                            ]},
                            "ref-sourcetitle": "Nurs Clin"
                        },
                        "ce:source-text": "Clark WA, Cress EM. Nutritional issues and positive living in human immunodeficiency virus/AIDS. Nurs Clin. 2018;53(1):13\u201324. doi:10.1016/j.cnur.2017.10.002"
                    }
                ]
            }}
        }
    },
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85092104472",
        "dc:description": "The extensive utilization of antiretroviral therapy (ART) has successfully improved human immunodeficiency virus (HIV)-associated complications. The incidence of opportunistic infections is decreased by the viral load suppression and the CD4 count promotion. However, metabolic complications, commonly bone demineralization, lipody-strophy, and lactic acidosis, are arising following the adaptation of long-term ART. The events are not drug-specific, but the severity and incidence individually vary depending upon classes of drugs. Such concerning occurrences may lead to discontinuation of current therapy or switching to another regimen with fewer adverse effects. The purpose of this review is to demonstrate the common metabolic abnormalities associated with each class of widely used ART in people living with HIV (PLHIV). Electronic databases such as PubMed, ScienceDirect, Scopus, Google Scholar, SciFinder, and Web of Science were used for the literature search. A better understanding of ART-associated metabolic adverse effects is helpful in various clinical settings so that therapists may optimize treatments in this population.",
        "prism:coverDate": "2020-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85092104472",
        "dc:creator": {"author": [{
            "ce:given-name": "Daylia",
            "preferred-name": {
                "ce:given-name": "Daylia",
                "ce:initials": "D.",
                "ce:surname": "Thet",
                "ce:indexed-name": "Thet D."
            },
            "@seq": "1",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Thet",
            "@auid": "57219293566",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219293566",
            "ce:indexed-name": "Thet D."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85092104472"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092104472&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85092104472&origin=inward"
            }
        ],
        "source-id": "19700175786",
        "citedby-count": "8",
        "prism:volume": "12",
        "subtype": "re",
        "dc:title": "Antiretroviral therapy-associated metabolic complications: Review of the recent studies",
        "openaccess": "1",
        "prism:issn": "11791373",
        "publishercopyright": "© 2020 Thet and Siritientong.",
        "subtypeDescription": "Review",
        "prism:publicationName": "HIV/AIDS - Research and Palliative Care",
        "prism:pageRange": "507-524",
        "prism:endingPage": "524",
        "openaccessFlag": "true",
        "prism:doi": "10.2147/HIV.S275314",
        "prism:startingPage": "507",
        "dc:identifier": "SCOPUS_ID:85092104472",
        "dc:publisher": "Dove Medical Press Ltd"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Antiretroviral therapy"
        },
        {
            "@_fa": "true",
            "$": "HIV"
        },
        {
            "@_fa": "true",
            "$": "Lipid profile"
        },
        {
            "@_fa": "true",
            "$": "Lipodystrophy"
        },
        {
            "@_fa": "true",
            "$": "Metabolic"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Health Policy",
            "@code": "2719",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Dermatology",
            "@code": "2708",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Virology",
            "@code": "2406",
            "@abbrev": "IMMU"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Daylia",
            "preferred-name": {
                "ce:given-name": "Daylia",
                "ce:initials": "D.",
                "ce:surname": "Thet",
                "ce:indexed-name": "Thet D."
            },
            "@seq": "1",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Thet",
            "@auid": "57219293566",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219293566",
            "ce:indexed-name": "Thet D."
        },
        {
            "ce:given-name": "Tippawan",
            "preferred-name": {
                "ce:given-name": "Tippawan",
                "ce:initials": "T.",
                "ce:surname": "Siritientong",
                "ce:indexed-name": "Siritientong T."
            },
            "@seq": "2",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Siritientong",
            "@auid": "36474194400",
            "author-url": "https://api.elsevier.com/content/author/author_id/36474194400",
            "ce:indexed-name": "Siritientong T."
        }
    ]}
}}